Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akari Therapeutics PLC

1.28
+0.07506.22%
Post-market: 1.280.00000.00%16:00 EDT
Volume:91.27K
Turnover:103.12K
Market Cap:36.96M
PE:-0.52
High:1.29
Open:1.29
Low:1.03
Close:1.21
Loading ...
Mar 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Correspondence

Form CORRESP - Correspondence
Oct 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 01, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 14, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 04, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Oct 12, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
May 16, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 30, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 21, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals